Ind-Swift Laboratories Ltd (INDSWFTLAB) — regulation 29 | 21 September 2026

21 September 2026 · BSE Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Essix Biosciences acquired 7 million fully convertible warrants in Ind-Swift Laboratories

🔄 What Changed

Promoter group stake increased from 37.92% to 43.06% post-acquisition

🔮 What's Next

Warrants will convert into equity shares on September 17, 2026

💡 Investor Takeaway

This acquisition increases the promoter group's ownership stake in the company

Ind-Swift Laboratories disclosed that Essix Biosciences acquired 7 million fully convertible warrants representing 5.13% of its voting capital, to be converted into equity shares on September 17, 2026. The transaction raises the promoter group's total stake to 43.06% post-acquisition, with warrants exercisable at ₹745 each. This regulatory filing under SEBI Regulation 29(2) details shareholding changes following a preferential allotment of warrants.

📄 View Original Announcement (PDF)

📊 Stock Analysis — INDSWFTLAB ✨ Ask AI About This

About Ind-Swift Laboratories Ltd (INDSWFTLAB)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹3,550.64 CrP/E: 59.9ROE: 4.1%ROCE: 5.2%

View full INDSWFTLAB stock details →

📡 Get AI alerts when INDSWFTLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INDSWFTLAB — Free

💡 Ask AI about this filing

"What is the conversion price and timeline for the warrants?""How will the new shareholding affect voting control?""What is the impact on share price and valuation?"

Ask AI Free →

📊 More INDSWFTLAB filings

Announcement — 28 September 2026Ind-Swift Laboratories informed physical security holders that SEBI mandates updating PAN, KYC, and ...
Announcement — 28 September 2026Ind-Swift Laboratories Ltd announced the closure of its trading window effective 1 October 2026, pro...
🔴 Announcement — 23 September 2026Ind-Swift Laboratories announced its schedule for an upcoming analyst and institutional investor mee...
🔴 Corporate Action — 17 September 2026Ind-Swift Laboratories announced the allotment of 7 million fully convertible warrants to Essix Bios...
🟡 Board Meeting — 5 September 2026Ind-Swift Laboratories announced its 31st Annual General Meeting scheduled for September 30, 2026, v...

See all INDSWFTLAB filings →

🔥 Also filed on 21 September 2026

BIOCONBiocon LtdAnnouncement 523373Mini Diamonds (India) LtdAnnouncement PATANJALIPatanjali Foods LtdAnnouncement PREMIERENEPremier Energies LtdAnnouncement 544900Complete Sports and Management India LimitedAnnouncement MCLOUDMagellanic Cloud LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INDSWFTLAB files new disclosures

Track INDSWFTLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.